Microbot Medical Inc (NASDAQ:MBOT) price on Wednesday, April 30, fall -5.73% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.47.
A look at the stock’s price movement, the close in the last trading session was $2.62, moving within a range at $2.39 and $2.57. The beta value (5-Year monthly) was 1.4. Turning to its 52-week performance, $3.38 and $0.82 were the 52-week high and 52-week low respectively. Overall, MBOT moved 63.58% over the past month.
Microbot Medical Inc’s market cap currently stands at around $85.82 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MBOT is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend MBOT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MBOT’s current price about 16.81% and 39.98% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.55, while 7-day volatility ratio is 11.31% and 15.09% in the 30-day chart. Further, Microbot Medical Inc (MBOT) has a beta value of 1.13, and an average true range (ATR) of 0.26.
If we refocus on Microbot Medical Inc (NASDAQ:MBOT), historical trading data shows that trading volumes averaged 2.73 over the past 10 days and 3.00 million over the past 3 months. The company’s latest data on shares outstanding shows there are 34.74 million shares.
The 8.78% of Microbot Medical Inc’s shares are in the hands of company insiders while institutional holders own 6.92% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.52 million on 2025-04-15, giving us a short ratio of 1.48. The data shows that as of 2025-04-15 short interest in Microbot Medical Inc (MBOT) stood at 1595.0 of shares outstanding, with shares short rising to 5.13 million registered in 2025-03-14. Current price change has pushed the stock 120.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MBOT stock continues to rise going into the next quarter.
